导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 3.62% | 1584/4773 |
| 近一周 | -1.29% | 1963/5465 |
| 近一月 | -8.62% | 5010/5421 |
| 近一季 | -19.23% | 4878/5231 |
| 近半年 | -1.00% | 1649/4920 |
| 近一年 | 7.63% | 1446/4394 |
| 近两年 | 115.75% | 460/2954 |
| 近三年 | 67.98% | 375/2253 |
| 成立以来 | 32.92% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-0.70% 1914/4961 |
36.72% 888/5312 |
- - |
- - |
| 2025 | 50.53% 459/4813 |
-1.74% 2767/3635 |
3.18% 1126/4076 |
49.93% 327/4524 |
-0.96% 2743/4813 |
| 2024 | 13.90% 1098/3463 |
-3.89% 1577/2808 |
-6.44% 1951/3014 |
29.02% 177/3129 |
-1.82% 1847/3463 |
| 2023 | -18.98% 1837/2656 |
2.21% 1407/2280 |
-7.26% 1821/2385 |
-9.50% 1838/2515 |
-5.55% 1391/2655 |
| 2022 | -29.84% 1618/2207 |
-20.78% 1574/1919 |
5.42% 905/2016 |
-17.90% 1657/2113 |
2.34% 968/2208 |
| 2021 | 13.20% 364/1822 |
-6.83% 1041/1255 |
26.17% 78/1330 |
-6.08% 898/1466 |
2.53% 569/1822 |
| 2020 | - - |
- - |
- - |
-0.07% 1049/1164 |
16.44% 170/1184 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 港股医疗ETF | 1.4546 | 31.90% |
| 华富中证港股通创新药指数型发起式A | 1.1637 | 30.96% |
| 天弘恒生沪深港创新药精选50ETF发起联接A | 1.3128 | 30.52% |
| 中欧中证港股通创新药指数发起A | 1.6103 | 30.52% |
| 嘉实中证港股通创新药指数发起式C | 0.8566 | 30.50% |
| 中欧中证港股通创新药指数发起C | 1.4583 | 30.44% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8927 | 30.26% |
| 景顺长城中证港股通创新药ETF联接C | 1.4696 | 29.97% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8736 | 29.94% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8719 | 29.88% |
| 浦银安盛创业板ETF VS. 长安沪深300非周期A(740101) |